Suppr超能文献

阿片促黑皮质素原受体药物研发的现状

The Current Status of Drug Discovery for the Oxytocin Receptor.

机构信息

Research School of Chemistry, Australian National University, Canberra, ACT, Australia.

出版信息

Methods Mol Biol. 2022;2384:153-174. doi: 10.1007/978-1-0716-1759-5_10.

Abstract

The oxytocin receptor plays a significant role in peripheral regulation of parturition and lactation. Given this important role, multiple drug discovery programs have been conducted to develop agonists and antagonists for peripheral activity. The role of the oxytocin receptor in the central nervous system is also significant, promoting social interaction, trust, and empathy in humans. As such, molecules that can access the central nervous system and target the oxytocin receptor are of significant interest. Due to the role of the oxytocin receptor in regulating social function and psychological well-being, agonists of this receptor have considerable promise for the treatment of numerous neuropsychiatric conditions. The poor pharmacokinetic properties and blood-brain barrier penetration of peptide-based molecules means nonpeptide compounds have more commonly been the focus for central nervous system activity. This chapter aims to summarize the current standing of peptide and nonpeptide drug discovery for antagonists and agonists of the oxytocin receptor and focusses on centrally active nonpeptidic agonists.

摘要

催产素受体在分娩和哺乳的外周调节中起着重要作用。鉴于其重要作用,已经开展了多项药物发现计划,以开发具有外周活性的激动剂和拮抗剂。催产素受体在中枢神经系统中的作用也很重要,它促进了人类的社交互动、信任和同理心。因此,能够进入中枢神经系统并靶向催产素受体的分子具有重要意义。由于催产素受体在调节社交功能和心理健康方面的作用,该受体的激动剂在治疗多种神经精神疾病方面具有很大的潜力。基于肽的分子的药代动力学性质和血脑屏障通透性较差,这意味着非肽化合物更常成为中枢神经系统活性的研究重点。本章旨在总结目前针对催产素受体的拮抗剂和激动剂的肽和非肽药物发现的现状,并重点介绍具有中枢活性的非肽类激动剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验